Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -23,720 | -26,135 |
| Depreciation Amortization | 116 | 56 |
| Accounts payable and accrued liabilities | 1,948 | N/A |
| Other Working Capital | 2,121 | 1,290 |
| Other Operating Activity | -1,297 | 1,667 |
| Operating Cash Flow | $-20,832 | $-23,122 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -1,898 | N/A |
| PPE Investments | -74 | -441 |
| Other Investing Activity | 0 | -10,970 |
| Investing Cash Flow | $-1,972 | $-11,411 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 720 | N/A |
| Other Financing Activity | 68,479 | 46,063 |
| Financing Cash Flow | $69,199 | $46,063 |
| Beginning Cash Position | 24,210 | 12,680 |
| End Cash Position | 70,605 | 24,210 |
| Net Cash Flow | $46,395 | $11,530 |
| Free Cash Flow | ||
| Operating Cash Flow | -20,832 | -23,122 |
| Capital Expenditure | -74 | N/A |
| Free Cash Flow | -20,906 | -23,122 |